Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.

Jandrot-Perrus M, Aurousseau MH, Rabiet MJ, Josso F.

Thromb Res. 1982 Sep 15;27(6):659-70.

PMID:
6217586
2.

Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.

Matsuda M, Saeki E, Kasamatsu A, Nakamikawa C, Manabe S, Samejima Y.

Thromb Res. 1985 Feb 1;37(3):379-90.

PMID:
3992527
3.

Fibrinogen Aarhus--a new case of dysfibrinogenemia.

Hessel B, Stenbjerg S, Dyr J, Kudryk B, Therkildsen L, Blombäck B.

Thromb Res. 1986 Apr 1;42(1):21-37.

PMID:
2939591
4.

A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine.

Yoshida N, Wada H, Morita K, Hirata H, Matsuda M, Yamazumi K, Asakura S, Shirakawa S.

Blood. 1991 May 1;77(9):1958-63.

5.
6.
8.

A hereditary dysfibrinogenemia: fibrinogen Awaji.

Matsuo T, Okuno S, Mukaida T, Ueshima S, Okada K, Matsuo O.

Haemostasis. 1987;17(1-2):89-97.

PMID:
3596361
9.

Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).

Meyer M, Kutscher G, Stürzebecher J, Riesener G, Lutze G.

Thromb Res. 2003 Jan 25;109(2-3):145-51.

PMID:
12706644
10.
11.

Fibrinogen Milano. VI: A heterozygous dysfibrinogenemia (A alpha 16 Arg----His) with bleeding tendency.

Bögli C, Cofrancesco E, Cortellaro M, Della Volpe A, Hofer A, Furlan M, Zanussi C.

Eur J Haematol. 1990 Jul;45(1):26-30.

PMID:
2379562
12.

Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.

Schreiber WE, Schmer G.

Thromb Res. 1985 Jan 1;37(1):45-52.

PMID:
3983901
13.

Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.

Andes WA, Chavin SI, Beltran G, Stuckey WJ.

Thromb Res. 1982 Jan 1-15;25(1-2):41-50.

PMID:
6801812
14.
15.

Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.

Tanaka H, Terasawa F, Ito T, Tokunaga S, Ishida F, Kitano K, Kiyosawa K, Okumura N.

Thromb Haemost. 2001 Jan;85(1):108-13.

PMID:
11204560
16.

Characterization of fibrinogen Milano I: amino acid exchange gamma 330 Asp----Val impairs fibrin polymerization.

Reber P, Furlan M, Rupp C, Kehl M, Henschen A, Mannucci PM, Beck EA.

Blood. 1986 Jun;67(6):1751-6.

17.

Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.

Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J.

Blood. 1991 Oct 1;78(7):1744-52.

18.

Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.

Rodeghiero F, Castaman GC, Dal Belin Peruffo A, Dini E, Galletti A, Barone E, Gastaldi G.

Thromb Haemost. 1987 Jun 3;57(3):252-8.

PMID:
2958952
19.

Fibrinogen Petoskey: identification of a new dysfibrinogenemia characterized by altered release of fibrinopeptide A.

Higgins DL, Penner JA, Shafer JA.

Thromb Res. 1981 Sep 15;23(6):491-504. No abstract available.

20.

Fibrinogen Seattle releases half the normal amount of fibrinopeptide B.

Branson HE, Schmer G, Theodor I, Pirkle H.

Acta Haematol. 1983;70(4):257-63.

PMID:
6414212

Supplemental Content

Support Center